Clinical and laboratory features of seven patients with acute myeloid leukemia (AML)-M2/M3 and elevated myeloblasts and abnormal promyelocytes

Table 2 Laboratory features of 7 patients with AML-M2/M3

Variable	Case 1	Case 2	Case 3	Case 4	Case 5	Case 6	Case 7	Higher than	Lower than
Variable	Case 1	Case 2	Case 3	Case 4	Case 5	Case 6	Case 7	Normal, n (%)	Normal, n(%)
WBC (×10⁹/L)	112	0.8	119.1	60.9	1.5	17.8	10.1	5(71.4)	2(28.6)
RBC (×10¹²/L)	4.1	1.6	3.3	2.6	2.2	3.8	3.56	0(0.0)	2(28.6)
HB (g/L)	122	57	93	82	77	105	119	0(0.0)	6(85.7)
Platelets (×10⁹/L)	75	18	18	26	52	65	39	0(0.0)	7(100)
LDH (U/L)	294	192	706	383	364	937	1037	6(85.7)	1(14.6)
PT (sec)	15.8	15.1	25.2	15.9	13.5	13.3	13.6	4(57.1)	0(0.0)
Fibrinogen (g/L)	1.4	5.1	0.6	2	3.6	3.1	4.23	2(28.6)	2(28.6)
D-dimer (ng/ml)	>10000	1249	3607	3310	821	-	881	6(85.7)	0(0.0)
BM Myeloblasts	62%	47.50%	39.50%	85%	42.50%	17%	49%	7(100)	0(0.0)
BM abnormal promyelocytes	38%	35.50%	49.50%	11.50%	30%	49.50%	29%	7(100)	0(0.0)
PB Myeloblasts	61%	0	47%	67%	1%	36%	14%	5(71.4)	0(0.0)
PB abnormal promyelocytes	17%	0	50%	24%	0	28%	13%	5(71.4)	0(0.0)
MPO of BM smears	62% strongly positive	94% strongly positive	99% positive	>90% strongly positive	99% positive	-	95% positive
AS-DCE of BM smears	48% positive	23% positive	70% positive	19% positive	>90% positive	-	50% positive
NSE of BM smears	-	8% weakly positive	<20% positive	>90% strongly positive	-	-	-

WBC, white blood cell count in peripheral blood; RBC, red blood cell count; HB, hemoglobin; LDH, lactate dehydrogenase; PT, prothrombin time; APTT, activated partial thromboplastin time; BM, bone marrow; PB, peripheral blood; MPO, myeloperoxidase; AS-DCE, naphthol AS-D chloroacetate esterase; NSE, non-specific esterase (or alpha-naphthol acetate esterase, a-NAE); -, no results available.

ISSN: 1475-2867